Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 390-394, March 2010

Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus

  • Shinsuke Yamada

      Affiliations

    • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan
  • ,
  • Masaaki Inaba

      Affiliations

    • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 6 6645 3806; fax: +81 6 6645 3808.
  • ,
  • Shigeki Okada

      Affiliations

    • Okada Clinic, Tennoji-ku, Osaka 543-0056, Japan
  • ,
  • Yasuo Imanishi

      Affiliations

    • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan
  • ,
  • Katsuhito Mori

      Affiliations

    • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan
  • ,
  • Masanori Emoto

      Affiliations

    • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan
  • ,
  • Eiji Ishimura

      Affiliations

    • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan
  • ,
  • Yoshiki Nishizawa

      Affiliations

    • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan

Received 16 February 2009; accepted 9 August 2009. published online 05 October 2009.

Abstract 

Sustained high glucose impairs bone metabolism in patients with type 2 diabetes mellitus (T2DM). In this study, the relationship between glycemic control and bone metabolism was examined in male hemodialysis (HD) patients with T2DM. To avoid the effect of menstruation and the menstrual cycle, obesity, and glycosuria-induced hypercalciuria on bone metabolism, male anuric nonobese HD patients with T2DM (n = 42) were enrolled. Calcaneus stiffness index (SI) was determined using ultrasound after HD session. Casual plasma glucose (PG), glycated hemoglobin (HbA1c), and glycated albumin (GA) were measured before the HD session. In simple regression analysis, log PG (r = −0.333, P < .05) and log GA (r = −0.350, P < .05), but not log HbA1c (r = −0.134, P = .3985), exhibited significant and negative correlations with calcaneus SI. In multiple regression analysis including log BMI, log cCa × Pi product, and log PG, log PG was associated significantly in a negative manner with calcaneus SI, in addition to log cCa × Pi product. When log PG was replaced with log GA or log HbA1c, log GA, but not log HbA1c, emerged as a significant factor associated. The mechanism as to why HbA1c failed to associate could be explained by its false reduction by erythropoietin injection. The present study supported the notion of GA as an appropriate indicator for glycemic control in HD patients with T2DM. Furthermore, it is suggested that poor glycemic control might be a significant factor toward decreasing calcaneus SI in T2DM HD patients.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(09)00340-0

doi:10.1016/j.metabol.2009.08.008

Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 390-394, March 2010